Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Vitamin D and its metabolites--supply of patients with various endocrine disorders and comparison of analytical methods

M Vosatkova, P Hoskovcova, R Bilek

. 2007 ; 41 (1) : 19-28.

Language English Country Slovakia

Document type Comparative Study

Grant support
1A8634 MZ0 CEP Register

OBJECTIVE: Vitamin D is important not only for its effect on the homeostasis of calcium, but also for its anti-proliferative, pro-differentiation, pro-apoptotic and immuno-modulating effects in the tissues of living organisms. This work describes the results of serum 25(OH)D (n=2175) and 1alpha,25(OH)2D (n=2271) radioimmunoassays (RIA) conducted at the Institute of Endocrinology in Prague (Czech Republic) during the period of 2004-2006. METHODS: Serum concentrations of vitamin D metabolites were determined by RIA kits from IDS Ltd., Boldon, UK. In a group of 20 healthy volunteers, results obtained using the RIA kit were compared with those obtained after serum extraction with acetonitrile, subsequent chromatographic (RP HPLC) separation of 25(OH)D and its detection in collected fractions using the same RIA kit from IDS. RESULTS: The mean concentrations +/- S.D. in the samples studied were 76.4 +/- 45.6 nmol/l for 25(OH)D and 88.9 +/- 45.1 pmol/l for 1alpha,25(OH)2D. The mean concentrations of both metabolites were higher in women than in men, but only the difference for 1alpha,25(OH)2D) was statistically significant (p=0.0000). The lowest concentrations of 25(OH)D or 1alpha,25(OH)2D were found in patients with hyperparathyroidism, the highest concentrations those treated with cholecalciferol for osteoporosis and vitamin D deficiency. The relationship between 25(OH)D and 1alpha,25(OH)2D was expressed by the equation 1alpha,25(OH)2D = 71.0845 + 0.1890 * 25(OH)D (n=1065, p=0.0000, R2=0.0343). Based on the RIA results, only 4 % of individuals were inadequately supplied with 25(OH)D, 79 % were supplied adequately and almost 17 % were supplied more than adequately. Similarly, 1alpha,25(OH)2D shows inadequate concentration in 15 % of the individuals tested, 59 % of these individuals were within the reference range and 26 % had values exceeding the upper limit of the reference range. The mean concentrations of 25(OH)D obtained by HPLC separation were in average by 8 % higher than those obtained using only the RIA kit. CONCLUSION: Interpretation of studies dealing with vitamin D stores must be based on precise and correct analytical procedures. However, only a few information exists about the influence of other vitamin D metabolites and conjugates on the concentration of immunoanalytically measured serum 25(OH)D or 1alpha,25(OH)2D.

000      
04172naa 2200529 a 4500
001      
bmc10015055
003      
CZ-PrNML
005      
20131011105126.0
008      
100623s2007 xo e eng||
009      
AR
035    __
$a (PubMed)17437341
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xo
100    1_
$a Vosátková, Karolína. $7 _AN028054
245    10
$a Vitamin D and its metabolites--supply of patients with various endocrine disorders and comparison of analytical methods / $c M Vosatkova, P Hoskovcova, R Bilek
314    __
$a Institute of Endocrinology, Czech Republic
520    9_
$a OBJECTIVE: Vitamin D is important not only for its effect on the homeostasis of calcium, but also for its anti-proliferative, pro-differentiation, pro-apoptotic and immuno-modulating effects in the tissues of living organisms. This work describes the results of serum 25(OH)D (n=2175) and 1alpha,25(OH)2D (n=2271) radioimmunoassays (RIA) conducted at the Institute of Endocrinology in Prague (Czech Republic) during the period of 2004-2006. METHODS: Serum concentrations of vitamin D metabolites were determined by RIA kits from IDS Ltd., Boldon, UK. In a group of 20 healthy volunteers, results obtained using the RIA kit were compared with those obtained after serum extraction with acetonitrile, subsequent chromatographic (RP HPLC) separation of 25(OH)D and its detection in collected fractions using the same RIA kit from IDS. RESULTS: The mean concentrations +/- S.D. in the samples studied were 76.4 +/- 45.6 nmol/l for 25(OH)D and 88.9 +/- 45.1 pmol/l for 1alpha,25(OH)2D. The mean concentrations of both metabolites were higher in women than in men, but only the difference for 1alpha,25(OH)2D) was statistically significant (p=0.0000). The lowest concentrations of 25(OH)D or 1alpha,25(OH)2D were found in patients with hyperparathyroidism, the highest concentrations those treated with cholecalciferol for osteoporosis and vitamin D deficiency. The relationship between 25(OH)D and 1alpha,25(OH)2D was expressed by the equation 1alpha,25(OH)2D = 71.0845 + 0.1890 * 25(OH)D (n=1065, p=0.0000, R2=0.0343). Based on the RIA results, only 4 % of individuals were inadequately supplied with 25(OH)D, 79 % were supplied adequately and almost 17 % were supplied more than adequately. Similarly, 1alpha,25(OH)2D shows inadequate concentration in 15 % of the individuals tested, 59 % of these individuals were within the reference range and 26 % had values exceeding the upper limit of the reference range. The mean concentrations of 25(OH)D obtained by HPLC separation were in average by 8 % higher than those obtained using only the RIA kit. CONCLUSION: Interpretation of studies dealing with vitamin D stores must be based on precise and correct analytical procedures. However, only a few information exists about the influence of other vitamin D metabolites and conjugates on the concentration of immunoanalytically measured serum 25(OH)D or 1alpha,25(OH)2D.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hyperparatyreóza $7 D006961
650    _2
$a kojenec $7 D007223
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a osteoporóza $x krev $7 D010024
650    _2
$a radioimunoanalýza $x metody $x normy $7 D011863
650    _2
$a referenční hodnoty $7 D012016
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a sexuální faktory $7 D012737
650    _2
$a neparametrická statistika $7 D018709
650    _2
$a vitamin D $x analogy a deriváty $x izolace a purifikace $x krev $7 D014807
650    _2
$a nedostatek vitaminu D $x krev $7 D014808
650    _2
$a financování organizované $7 D005381
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Hoskovcová, Petra $7 xx0076635
700    1_
$a Bílek, Radovan, $d 1954- $7 jo20000074070
773    0_
$t Endocrine Regulations $w MED00001518 $g Roč. 41, č. 1 (2007), s. 19-28 $x 1210-0668
910    __
$a ABA008 $b A 3699 $y 8 $z 0
990    __
$a 20100701105707 $b ABA008
991    __
$a 20131011105650 $b ABA008
999    __
$a ok $b bmc $g 750923 $s 614601
BAS    __
$a 3
BMC    __
$a 2007 $b 41 $c 1 $d 19-28 $i 1210-0668 $m Endocrine regulations $n Endocr. Regul. $x MED00001518
GRA    __
$a 1A8634 $p MZ0
LZP    __
$a 2010-B1/mkme

Find record

Citation metrics

Logged in users only

Archiving options

Loading data ...